-----begin privacy-enhanced message----- proc-type: 2001,mic-clear originator-name: webmaster@www.sec.gov originator-key-asymmetric: mfgwcgyevqgbaqicaf8dsgawrwjaw2snkk9avtbzyzmr6agjlwyk3xmzv3dtinen twsm7vrzladbmyqaionwg5sdw3p6oam5d3tdezxmm7z1t+b+twidaqab mic-info: rsa-md5,rsa, azojm1n9fld4xdrwlfxvbw/yoakcipbouseir6vyik8him0wyj7xnl4rzqhm/lcm 5soo229fxvoirlrjv+3gcw== 0001144204-06-027831.txt : 20060707 0001144204-06-027831.hdr.sgml : 20060707 20060707173105 accession number:		0001144204-06-027831 conformed submission type:	sc 13d public document count:		1 filed as of date:		20060707 date as of change:		20060707 subject company:	 	company data:	 		company conformed name:			finity holdings inc 		central index key:			0001051985 		standard industrial classification:	services-computer processing & data preparation [7374] 		irs number:				113210792 		state of incorporation:			de 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-53749 		film number:		06952094 	business address:	 		street 1:		5155 financial way 		street 2:		- 		city:			mason 		state:			oh 		zip:			45040 		business phone:		5132296663 	mail address:	 		street 1:		511 f street, #504 		street 2:		- 		city:			san diego 		state:			ca 		zip:			92101 	former company:	 		former conformed name:	columbia capital corp/tx/ 		date of name change:	19971223 filed by:		 	company data:	 		company conformed name:			finity holdings inc 		central index key:			0001051985 		standard industrial classification:	services-computer processing & data preparation [7374] 		irs number:				113210792 		state of incorporation:			de 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 	business address:	 		street 1:		5155 financial way 		street 2:		- 		city:			mason 		state:			oh 		zip:			45040 		business phone:		5132296663 	mail address:	 		street 1:		511 f street, #504 		street 2:		- 		city:			san diego 		state:			ca 		zip:			92101 	former company:	 		former conformed name:	columbia capital corp/tx/ 		date of name change:	19971223 sc 13d 1 v047152_sc-13d.htm unassociated document securities and exchange commission washington, dc 20549 schedule 13d (rule 13d-102) information to be included in statements filed pursuant to rule 13d-1(a) and amendments thereto filed pursuant to rule 13d-2(a) &#160; patients &amp; physicians, inc. (formerly known as finity holdings, inc.) (name of issuer) common stock, par value $0.001 per share (title of class of securities) &#160; 70322k109 (cusip number) mr. fred f. nazem c/o&#160; patients &amp; physicians , inc. 432 park avenue south, 13 th floor new york, ny 10016 (212) 340-9100 (name, address, and telephone number of person authorized to receive notices and communications) 6/27/2006 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d, and is filing this schedule because of rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. /_/ note. schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see rule 13d-7 for other parties to whom copies are to be sent. *the remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of section 18 of the securities exchange act of 1934 (&#8216;act&#8221;) or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes ). &#160; &#160; &#160; cusip no. 197351208 page 2 of 9 pages&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; 1. name of reporting persons&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; flagship patient advocates, inc. (formerly flagship healthcare management, inc.) s.s. or i.r.s. identification no. of above person (entities only) 04-3701029 &#160; 2. check the appropriate box if a member of a group (see instructions) (a)&#160;&#160; o (b)&#160;&#160; x &#160; 3. sec use only &#160; 4. source of funds (see instructions) [oo] &#160; 5. check box if disclosure of legal proceedings is required pursuant to item 2(d) or 2(e) o &#160; 6. citizenship or place of organization delaware number of shares beneficially owned by the reporting person with 7. sole voting power 11,316,230* 8. shared voting power -0- 9. sole dispositive power 11,316,230* 10. shared dispositive power -0- &#160; 11. aggregate amount beneficially owned by the reporting person 11,316,230* &#160; 12. check box if the aggregate amount in row (11) excludes certain shares o &#160; 13. percent of class represented by amount in row (11) 19.83 % &#160; 14. type of reporting person co &#160; *the board of directors of the company has the right to vote all of the shares of common stock owned by dr. o&#8217;brien. -2- &#160; &#160; &#160; cusip no. 197351208 page&#160;3 of 9 pages&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; 1. name of reporting persons&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; stephen j. o&#8217;brien i.r.s. identification no. of above person (entities only) &#160; 2. check the appropriate box if a member of a group (see instructions) (a)&#160;&#160; o (b)&#160;&#160; x &#160; 3. sec use only &#160; 4. source of funds (see instructions) [oo] &#160; 5. check box if disclosure of legal proceedings is required pursuant to item 2(d) or 2(e) o &#160; 6. citizenship or place of organization united states number of shares beneficially owned by the reporting person with 7. sole voting power 11,316,230* 8. shared voting power -0- 9. sole dispositive power 11,316,230* 10. shared dispositive power -0- &#160; 11. aggregate amount beneficially owned by the reporting person 11,316,230* &#160; 12. check box if the aggregate amount in row (11) excludes certain shares o &#160; 13. percent of class represented by amount in row (11) 19.83 % &#160; 14. type of reporting person in &#160; *the board of directors of the company has the right to vote all of the shares of common stock owned by dr. o&#8217;brien. -3- &#160; item 1. security and issuer. this schedule 13d ( this &#8220;schedule 13d&#8221;), relates to common stock, par value $.001 (&#8220;common stock&#8221;) , of patients &amp; physicians, inc. (formerly finity holdings, inc.), a delaware corporation (the "issuer"). the principal executive offices of the issuer are located at 432 park avenue south, 13 th floor, new york, ny 10016 . item 2. identity and background. &#160; (a) this schedule 13d is being filed jointly by flagship patient advocates, inc. (formerly flagship healthcare management, inc. ) (&#8220;flagship&#8221;) and stephen j. o&#8217;brien (&#8220;o&#8217;brien&#8221;). the foregoing persons are hereinafter sometimes referred to collectively as the &#8220;reporting persons.&#8221; (b)-(c) flagship is a delaware corporation. flagship is engaged in the providing of healthcare advocacy services. the address of flagship&#8217;s principal office and principal place of business is 432 park avenue south, 13 th floor, new york, ny 10016. dr. o&#8217;brien is a natural person, and his principal occupation is a physician . the address of his principal office and principal place of business is 535 east 70th street, new york, ny 10021. &#160; (d)-(e) during the last five years none of the reporting persons has (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws. (f) dr. o&#8217;brien is a citizen of the united states of america. &#160; item 3. source and amount of funds or other consideration. &#160; on june 27, 2006, in connection with the consummation of the share exchange agreement between flagship and the issuer (the &#8220;share exchange&#8221;), o&#8217;brien acquired 11,316,230 shares of the issuer&#8217;s capital stock. &#160; item 4. purpose of transaction. in connection with the consummation of the share exchange, o&#8217;brien acquired 11,316,230 shares of the issuer&#8217;s capital stock. o&#8217;brien acquired the securities of the issuer for general investment purposes. notwithstanding the foregoing, o&#8217;brien retains the right to change his investment intent, to propose one or more possible transactions to the issuer's board of directors, to acquire additional securities from time to time or to sell or otherwise dispose of all or part of the securities beneficially owned by him in any manner permitted by law. &#160; -4- except as set forth above, neither of the reporting persons has any plans or proposals which the reporting persons may have which relate to or would result in: (a) the acquisition by any person of additional securities of the issuer or the disposition of securities of the issuer. (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. (c) a sale or transfer of a material amount of assets of the issuer or of any of its subsidiaries. (d) any other material change in the issuer's business or corporate structure. (e) any material change in the present capitalization or dividend policy of the issuer other than as described herein. (f) any other material changes in the issuer's business or corporate structure. (g) any changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition or control of the issuer by any person. h) the securities of the issuer to be delisted from a national securities exchange or to cease to be authorized or to be quoted in an inter-dealer quotation system of a registered national securities association. (i) in a class of equity securities of the issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the act. (j) any action similar to any of those enumerated above. &#160; item 5. interest in securities of the issuer. (a) see items 11 and 13 of the cover pages to this schedule 13d for the aggregate number of common stock and percentage of common stock beneficially owned by each of the reporting persons. (b) see items 7 through 10 of the cover pages to this schedule 13d for the number of common stock beneficially owned by each of the reporting persons as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote and sole or shared power to dispose or to direct the disposition. (c) neither of the reporting persons has effected any transactions in the class of securities described in the past 60 days. (d) to the knowledge of the reporting persons, no person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities covered by this schedule 13d. (e) not applicable. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer. on january 30, 2006, flagship and the shareholders (the &#8220;shareholders&#8221;) of flagship entered into the share exchange agreement with the issuer, pursuant to which the issuer acquired all of the issued and outstanding capital stock of flagship from the shareholders in exchange for an aggregate of 55,685,255 &#160; newly-issued shares of the issuer&#8217;s common stock. -5- item 7. material to be filed as exhibits. exhibit 1. &#160; joint filing agreement dated july 7, 2006. exhibit 2.&#160; share exchange agreement between patients &amp; physicians, inc. (formerly finity holdings, inc. ) and flagship patient advocates, inc. (formerly flagship healthcare management, inc. ) , dated january 30, 2006 (incorporated by reference to the form 8-k of finity holdings, inc., filed february 3, 2006). -6- &#160; s i g n a t u r e after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete, and correct. &#160; &#160;date: july 7, 2006 &#160; flagship patient advocates , inc. &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; by: /s/ fred f. nazem &#160; name: fred f. nazem &#160; title: authorized representative &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; /s/&#160;stephen j. o&#8217;brien &#160; stephen j. o&#8217;brien &#160; &#160; &#160; &#160; -7- exhibit 1 joint filing agreement pursuant to rule 13d-1(k)(1) in accordance with rule 13d-1(k) under the securities exchange act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on schedule 13d with respect to the common stock of finity holdings, inc., and that this agreement be included as an exhibit to such joint filing. in witness whereof, the undersigned hereby execute this agreement this 7 th day of july, 2006. &#160; &#160; &#160; flagship patient advocates , inc. &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; by: /s/ fred f. nazem &#160; name: fred f. nazem &#160; title: authorized representative &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; /s/&#160;stephen j. o&#8217;brien &#160; stephen j. o&#8217;brien &#160; &#160; &#160; -8- -----end privacy-enhanced message----- 